Brazilian generics market change after Farmácia Popular program

Brazilian generics market change after Farmácia Popular program

ABSTRACT OBJECTIVE To evaluate trends in the use of generic and non-generic medicines to treat hypertension and diabetes under the Farmácia Popular Program (FP) and its impact on generic medicines sales volume and market share in the Brazilian pharmaceutical market. METHODS This longitudinal, retr...

Full description

Bibliographic Details
Main Authors:	Andréa Dâmaso Bertoldi, Luisa Arueira Chaves, Dennis Ross-Degnan, Vera Lucia Luiza, Isabel Cristina Martins Emmerick, Rondineli Mendes da Silva, Mônica Rodrigues Campos
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2019-10-01
Series:	Revista de Saúde Pública
Subjects:	Drugs, Generic, economics Generic Drug Policy Antihypertensive Agents, supply & distribution Hypoglycemic Agents, supply & distribution
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102019000100281&tlng=en

Similar Items

The Brazilian private pharmaceutical market after the first ten years of the generics law
by: Andréa Dâmaso Bertoldi, et al.
Published: (2019-12-01)

Financial incentives for generic drugs: case study on a reimbursement program
by: Marcos Inocencio, et al.
Published: (2010-06-01)

Financial incentives for generic drugs: case study on a reimbursement program
by: Marcos Inocencio, et al.
Published: (2010-06-01)

COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

Factors influencing the use of the “not for generic substitution” mention for prescriptions in primary care: a survey with general practitioners
by: Virgil Beauvais, et al.
Published: (2018-11-01)

Do Farmers Get an Equal Bang for Their Buck from Generic Advertising Programs? A Theoretical and Empirical Analysis
by: Chanjin Chung, et al.
Published: (2000-07-01)

Opinions of Czech general practitioners on generic drugs and substitution
by: Dosedel Martin, et al.
Published: (2014-12-01)

The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population
by: Joshua D. Brown, et al.
Published: (2016-03-01)

Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
by: F. Cankat Tulunay, et al.
Published: (2010-08-01)

Antimicrobial drug-nutrition interactions: Consistency of information for generic drugs
by: Nikolić Božana
Published: (2020-01-01)

New prices for generic equivalent drugs
by: Ombretta Bandi
Published: (2011-11-01)

THE POSPONT RESULTS OF SWITCHING ON TOPIRAMAT GENERICS AT PATIENTS WITH EPILEPSY
by: I. G. Rudakova
Published: (2016-05-01)

ORIGINAL OR GENERIC DRUG: THE PROBLEM OF CHOICE OF ANTIBIOTIC DRUGS IN RUSSIA
by: A. I. SINOPALNIKOV, et al.
Published: (2016-12-01)

A comparison of generic drug prices in seven European countries: a methodological analysis
by: Olivier J. Wouters, et al.
Published: (2017-03-01)

Generic Medicine and Generic Prescribing in Nepal: An Implication for Policymakers
by: Shrestha R, et al.
Published: (2022-02-01)

Generic substitutions of antiepileptic drugs: Is it possible to put an end to the discussion?
by: E. A. Ushkalova, et al.
Published: (2018-07-01)

The Potential to Reduce Patient Co-Payment and the Public Payer Spending in Poland through an Optimised Implementation of the Generic Substitution: The Win-Win Scenario Suggested by the Real-World Big Data Analysis
by: Przemysław Kardas, et al.
Published: (2021-07-01)

Physicians’ generic drug prescribing behavior in district hospitals: a case of Phitsanulok, Thailand
by: Plianbangchang P, et al.
Published: (2010-09-01)

The problem of choosing between the original and of generic drugs in patients with overweight and obesity
Published: (2013-10-01)

Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration
by: Reddy M Vivek, et al.
Published: (2022-03-01)

A comparative study of the efficacy and safety of the original and generic orlistat in obese patients in the PROFIL register
by: A. V. Zakharova, et al.
Published: (2016-03-01)

Scientific and regulatory approaches to confirm quality and improve patient perceptions of generic drug products in Japan
by: Hiroko Shibata, et al.
Published: (2016-10-01)

Analiza nawyków i zachowań związanych ze stosowaniem leków oryginalnych i generycznych = The analysis of behaviour related to the use of original and generic drugs
by: Piotr Kozłowski, et al.
Published: (2015-08-01)

Analiza nawyków i zachowań związanych ze stosowaniem leków oryginalnych i generycznych = The analysis of behaviour related to the use of original and generic drugs
by: Piotr Kozłowski, et al.
Published: (2015-08-01)

Design and rationale for the WARFA trial: a randomized controlled cross-over trial testing the therapeutic equivalence of branded and generic warfarin in atrial fibrillation patients in Brazil
by: Carolina Gomes Freitas, et al.
Published: (2017-06-01)

Representative sample survey on factors determining the Czech physicians’ awareness of generic drugs and substitution
by: J. Maly, et al.
Published: (2019-10-01)

Preschool children’s sensitivity to the generic and non-generic distinctions
by: Marti Palla
Published: (2019-03-01)

Generic drugs: myths, facts, and limitations
by: Antonio Marzo, et al.
Published: (2012-10-01)

The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
by: Karan eThakkar, et al.
Published: (2013-09-01)

Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study
by: Mattioli F, et al.
Published: (2017-08-01)

WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

Antipsychotics use in the community of Thessaloniki, Greece
by: Papaioannidou Paraskevi, et al.
Published: (2018-01-01)

Real-world effectiveness of generic antihypertensive drugs of pradhan mantri bhartiya janaushadhi kendra
by: Chandani Sheikh, et al.
Published: (2022-01-01)

THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

Generic drug product development : solid oral dosage forms /
by: Shargel, Leon 1941-, editor, et al.
Published: (c201)

Perception of generic drugs among residents in a district of Peru
by: Ambrocio Teodoro Esteves Pairazaman, et al.
Published: (2023-11-01)

The Impact of Tiered-Pricing Framework on Generic Entry in Canada
by: Wei Zhang, et al.
Published: (2022-06-01)

A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA
by: V. P. Voronina, et al.
Published: (2016-01-01)

Blockchain Adoption for Generic Drugs in the Medicine Supply Chain with Consumers’ Risk-Aversion: A Game-Theoretic Model Within Chinese Legal Framework
by: Cui Z, et al.
Published: (2024-01-01)

The Portuguese generic medicines market: A policy analysis.
by: Simoens S
Published: (2009-06-01)